Tracing Potential Covalent Inhibitors of an E3 Ubiquitin Ligase through Target-Focused Modelling

por Bjij, Imane, Ramharack, Pritika, Khan, Shama, Cherqaoui, Driss, Soliman, Mahmoud E. S.
Publicado 2019

COVID-19: In silico identification of potent α-ketoamide inhibitors targeting the main protease of the SARS-CoV-2

por Oubahmane, Mehdi, Hdoufane, Ismail, Bjij, Imane, Jerves, Carola, Villemin, Didier, Cherqaoui, Driss
Publicado 2021

Design of Potent Inhibitors Targeting the Main Protease of SARS-CoV-2 Using QSAR Modeling, Molecular Docking, and Molecular Dynamics Simulations

por Oubahmane, Mehdi, Hdoufane, Ismail, Delaite, Christelle, Sayede, Adlane, Cherqaoui, Driss, El Allali, Achraf
Publicado 2023

In Silico SAR Studies of HIV-1 Inhibitors

por Hdoufane, Ismail, Bjij, Imane, Soliman, Mahmoud, Tadjer, Alia, Villemin, Didier, Bogdanov, Jane, Cherqaoui, Driss
Publicado 2018

Hybrid Molecules as Potential Drugs for the Treatment of HIV: Design and Applications

por Liman, Wissal, Ait Lahcen, Nouhaila, Oubahmane, Mehdi, Hdoufane, Ismail, Cherqaoui, Driss, Daoud, Rachid, El Allali, Achraf
Publicado 2022

Monte Carlo Method and GA-MLR-Based QSAR Modeling of NS5A Inhibitors against the Hepatitis C Virus

por Liman, Wissal, Oubahmane, Mehdi, Hdoufane, Ismail, Bjij, Imane, Villemin, Didier, Daoud, Rachid, Cherqaoui, Driss, El Allali, Achraf
Publicado 2022